KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Interest Coverage Ratio (2018 - 2025)

Historic Interest Coverage Ratio for TherapeuticsMD (TXMD) over the last 12 years, with Q3 2025 value amounting to 287.33.

  • TherapeuticsMD's Interest Coverage Ratio rose 2398.59% to 287.33 in Q3 2025 from the same period last year, while for Sep 2025 it was 246.86, marking a year-over-year increase of 7041.86%. This contributed to the annual value of 2.42 for FY2021, which is 5557.78% up from last year.
  • Latest data reveals that TherapeuticsMD reported Interest Coverage Ratio of 287.33 as of Q3 2025, which was up 2398.59% from 347.5 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Interest Coverage Ratio registered a high of 1.24 during Q1 2022, and its lowest value of 557.8 during Q2 2024.
  • Its 5-year average for Interest Coverage Ratio is 170.91, with a median of 54.93 in 2023.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first skyrocketed by 6479.53% in 2021, then tumbled by 420062.14% in 2023.
  • TherapeuticsMD's Interest Coverage Ratio (Quarter) stood at 4.67 in 2021, then skyrocketed by 73.45% to 1.24 in 2022, then tumbled by 7047.55% to 88.65 in 2023, then tumbled by 326.4% to 378.0 in 2024, then increased by 23.99% to 287.33 in 2025.
  • Its last three reported values are 287.33 in Q3 2025, 347.5 for Q2 2025, and 435.5 during Q1 2025.